🚨 The MIC That Lied: When Cefiderocol Should Never Be “Susceptible”

By FRCPathPrep.com

If you’re preparing for FRCPath Medical Microbiology Part 2, here’s a truth that separates safe consultants from dangerous confidence:

A low MIC without a breakpoint is not clever — it’s misleading.

And nowhere is this more exam-lethal (or patient-riskier) than cefiderocol reported as “susceptible” for staphylococci.

🧨 The Shock Factor

Picture this OSPE:

• Blood culture: MRSA

• AST table looks pristine

• And then…Cefiderocol MIC 0.5 mg/L — S

Your heart skips. ICU wants “salvage therapy”.Your examiner is watching.

This is the moment candidates either win distinction marks… or fail quietly.

❌ Why This Result Is Flat-Out Wrong

Cefiderocol is a siderophore cephalosporin engineered to hijack Gram-negative iron transport systems.

Staphylococci don’t use those systems.

That’s not nuance. That’s biology.

Under EUCAST:

• No clinical breakpoints exist for Staphylococcus spp.

• Therefore:

  • No S / I / R

  • No valid MIC interpretation

  • No clinical use

If there’s no breakpoint, the MIC is clinically meaningless — no matter how pretty the number looks.

🧠 The EUCAST Rule Every Examiner Loves

Say this and you’ll feel the room nod:

“No breakpoint = no interpretation = no use.”

EUCAST doesn’t leave grey zones here.Labs should not test, not report, and not influence therapy with agents lacking breakpoints.

Anything else is a patient safety issue.

🧪 How This Error Actually Happens

Let’s be honest — you will see this in real labs:

• Automated AST panels running unchecked

• “Everything switched on” mentality

• MICs reported because the machine allowed it

• No human applied EUCAST logic

This is exactly why FRCPath Part 2 examiners love this trap:It tests whether you can override the machine.

🎯 What a Consultant-Level Answer Sounds Like

When ICU asks, “Can we use cefiderocol?”:

“No. Cefiderocol is not recommended for staphylococcal infections. EUCAST provides no breakpoints, so the MIC is uninterpretable. Effective alternatives include vancomycin, daptomycin, linezolid, or ceftaroline depending on site and context.”

That’s not defensive.That’s authoritative.

⚠️ The Top Ways Candidates Lose Marks

• ❌ “The MIC is low, so it might work”

• ❌ “FDA approved it”

• ❌ “As salvage therapy maybe…”

• ❌ Failing to challenge the report itself

Remember:Examiners aren’t testing drugs — they’re testing judgment.

💎 The FRCPathPrep Take-Home

If you remember only one line, make it this:

A reported MIC without an EUCAST breakpoint is a trap — not a treatment.

At FRCPathPrep.com, we don’t teach lists.We teach how examiners think, how labs fail, and how consultants prevent harm.